>UFP-102 | C-terminal glutamine residue is amidated; phenylalanine residue at position 4 is fluorinated in the 4th position of the phenyl ring 
FGGFTGARKSARKRKNQ
>[(pF)Phe<sup>4</sup>]N/OFQ-(1-13)-NH<sub>2</sub> | C-terminal lsyine is amidated; phenylalanine residue at position 4 has fluorine substituted for one of its hydrogen atoms 
FGGFTGARKSARK
>N/OFQ-NH<sub>2</sub> | Amidation of C-terminal glutamine residue 
FGGFTGARKSARKLANQ
>N/OFQ-(1-13)-NH<sub>2</sub> | Amidation of C-terminal lysine residue 
FGGFTGARKSARK
>nociceptin/orphaninFQ{Sp:Human,Mouse,Rat} |  
FGGFTGARKSARKLANQ
>Ac-RYYRWK-NH<sub>2</sub> | Acetylation of N-terminal arginine residue; amidatiojn of C-terminal lysine residue 
RYYRWK
>[Arg<sup>14</sup>Lys<sup>15</sup>]N/OFQ | Leucine residue at postion 14 of the natural sequence and asparagine at position 15 are replaced by arginine and lysine respectively 
FGGFTGARKSARKRKNQ
>[F/G]N/OFQ-(1-13)-NH<sub>2</sub> | Residue 2 is &psi;(CH<sub>2</sub>-NH)Gly; C-terminal alanine is amidated 
FGGFTGARKSARKLA
>Ac-RYYRIK-NH<sub>2</sub> |  
RYYRIK
>UFP-112 | C-terminal glutamine residue is amidated; phenylalanine residue at position 4 is fluorinated in the 4th position of the phenyl ring; residue 7 is &alpha;-aminoisobutyric acid (&alpha;-methylalanine) | Original:FGGFTGXRKSARKRKNQ
FGGFTGFRKSARKRKNQ
>UFP-101 | C-terminal glutamine residue is amidated; N-terminal glycine residue is N-benzyl glycine 
GGGFTGARKSARKRKNQ
>[Nphe<sup>1</sup>]N/OFQ-(1-13)-NH<sub>2</sub> | N-terminal phenylalanine in the natural sequence is replaced by N-benzylglycine. Amidation of C-terminal lysine residue 
FGGFTGARKSARK
